The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Immunizations in Immunocomprised Patients

Immunizations in Immunocomprised Patients

August 1, 2009 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

SAN FRANCISCO—Rheumatologists face several questions when choosing appropriate vaccinations for their patients with rheumatoid arthritis (RA) and other diseases such as lupus that may be treated with immunosuppressive agents. Some, in fact, may wonder whether vaccinations should be given at all because their patients are likely to have a reduced immunologic response. Camille N. Kotton, MD, adopts a glass-half-full approach to influenza and pneumonia vaccinations in this vulnerable population. “As someone who deals with very ill immunocompromised patients, I feel strongly that some immunologic protection is better than none,” she asserted in the session, “Immunization in the Immunosuppressed Host,” held at the 2008 ACR/ARHP Annual Scientific Meeting.

You Might Also Like
  • Immunizations and Autoimmune Disease
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • H1N1 Influenza A Virus Brings Many Questions, Few Answers
Explore This Issue
August 2009
Also By This Author
  • In Memoriam: Paul A. Bacon, MD

Dr. Kotton is clinical director of the Transplant and Immunocompromised Host Infectious Diseases Group at Massachusetts General Hospital, Boston; assistant professor at Harvard Medical School, Boston; and president of the Transplantation Infectious Diseases Section at the Transplantation Society. She explained that her stance on influenza and pneumococcus vaccination has been informed by her experience at Massachusetts General, where vaccination of immunocompromised transplant recipients on the transplant service has become routine. “You may not always be able to prevent disease,” she noted, “but the disease we do see may be significantly attenuated.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

More Vulnerable

Patients with rheumatic diseases have twice the risk of acquiring infection than those in the general population.1 However, the question often arises as to whether vaccines might precipitate or worsen rheumatologic disease. Dr. Kotton pointed out that the jury is still out on this question: Most of the arguments against the use of vaccines are based on case reports, which are inadequate to establish a link between immunizations and worsening of preexisting rheumatologic disease. In addition, possible mechanisms of viral-induced autoimmunity (e.g., change in the host antigen and expression of HLA antigen) have yet to establish how vaccinations could trigger autoimmunity.

In the meantime, some guidance is available from several studies that show that influenza and pneumococcus vaccines are basically safe in patients with rheumatic disease. Dr. Kotton summarized several investigations that have demonstrated differing seroconversion rates in response to influenza, pneumococcus, and tetanus vaccines in RA and systemic lupus erythematosus patient populations. Again, Dr. Kotton repeated her assertion that some protection is better than none. She also suggested that clinicians might consider giving the flu vaccine later in the fall (closer to November) so that patients would have greater immunity coverage for the duration of the flu season, which tends to hit in December.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Drug Updates, Safety Tagged With: ACR/ARHP Annual Scientific Meeting, Diagnosis, Immunization, Treatment, vaccinationIssue: August 2009

You Might Also Like:
  • Immunizations and Autoimmune Disease
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • H1N1 Influenza A Virus Brings Many Questions, Few Answers
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)